APOTEX AUSTRALIA — Simvastatin Importer Profile
Pharmaceutical Importer · #15 buyer for Simvastatin · $712.9K import value · 68 shipments · AUSTRALIA · DGFT Verified
APOTEX AUSTRALIA is the #15 importer of Simvastatin from India with $712.9K in import value and 68 verified shipments. APOTEX AUSTRALIA holds a 0.5% market share in Simvastatin imports based in AUSTRALIA. The company sources from 1 verified supplier across 51 formulations shipped to 1 country. Overall, APOTEX AUSTRALIA imports 3 pharmaceutical products worth $1.5M across 3 therapeutic categories.
APOTEX AUSTRALIA — Simvastatin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Simvastatin to APOTEX AUSTRALIA?
Verified from 68 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| CIPLA LIMITED | $712.9K | 68 | 100.0% |
APOTEX AUSTRALIA sources Simvastatin from 1 verified Indian supplier based on 68 customs records. The primary supplier is CIPLA LIMITED accounting for 100.0% of imports.
How Does APOTEX AUSTRALIA Compare to Nearest Simvastatin Importers?
Buyers ranked immediately above and below #15 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | AMB HK ENTERPRISES INC. | PHILIPPINES | $700.0K | 14 | $50.0K |
| 14 | ASCEND LABORATORIES,LLC | UNITED STATES | $684.1K | 30 | $22.8K |
| 15 | APOTEX AUSTRALIA ★ | AUSTRALIA | $672.1K | 63 | $10.7K |
| 9 | XXRTHXXAR XXALTXXAREX | UNITED STATES | $600.0K | 12 | $50.0K |
| 16 | SIVEM PHARMACEUTICALS | CANADA | $587.8K | 98 | $6.0K |
APOTEX AUSTRALIA ranks #15 among 421 Simvastatin importers from India. Average shipment value of $10.7K compared to the market average of $60.3K. The closest competitors by value are AMB HK ENTERPRISES INC. and ASCEND LABORATORIES,LLC.
Where Does APOTEX AUSTRALIA Import Simvastatin To?
Destination countries from 68 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| AUSTRALIA | $712.9K | 68 | 100.0% |
APOTEX AUSTRALIA imports Simvastatin to 1 country. The primary destination is AUSTRALIA receiving 100.0% of shipments worth $712.9K.
What Simvastatin Formulations Does APOTEX AUSTRALIA Import?
| Formulation | Value | Shipments |
|---|---|---|
| APO-SIMVASTATIN 40MG TABLET SIMVASTATIN | $63.1K | 4 |
| APO-SIMVASTATIN 40MG TABLET (SIMVASTATIN | $54.9K | 5 |
| APO-SIMVASTATIN 20MG TABLET (SIMVASTATIN | $47.0K | 3 |
| APO-SIMVASTATIN 40MG TABLET (SIMVASTATIN 40MG). (INV.QTY. 18760 PACK3X10'S=562800 NOS) | $25.7K | 2 |
| APO-SIMVASTATIN 10 MG TABLET ( SIMVASTAT | $25.2K | 3 |
| APO-SIMVASTATIN 80 MG TABLET (SIMVASTATI | $21.7K | 2 |
| APO-SIMVASTATIN 80 MG TABLET SIMVASTATI | $20.0K | 2 |
| APO-SIMVASTATIN 20MG TABLET (SIMVASTATIN 20MG) (INV.QTY. 37680 PACK 2X15'S= 1130400 NOS) | $18.4K | 1 |
| APO-SIMVASTATIN 20MG TABLET (SIMVASTATIN 20MG) (INV.QTY. 37100PACK 2X15'S= 1113000 NOS) | $18.1K | 1 |
| APO-SIMVASTATIN 20MG TABLET (SIMVASTATIN 20MG) (INV.QTY. 38160 PACK 2X15'S=1144800 NOS) | $17.7K | 1 |
APOTEX AUSTRALIA imports 51 distinct Simvastatin formulations from India. The top formulation is APO-SIMVASTATIN 40MG TABLET SIMVASTATIN with 4 shipments worth $63.1K.
Regulatory Requirements: Importing Simvastatin into Australia
What APOTEX AUSTRALIA and other importers must comply with to import Simvastatin from India
Regulatory Authority
Therapeutic Goods Administration (TGA)
Approval Process for Generic Simvastatin
Application for registration on the Australian Register of Therapeutic Goods (ARTG). Generic pathway requires bioequivalence and quality data per TGA guidelines.
Typical timeline: 10–14 months
GMP Requirements
TGA GMP clearance; PIC/S-aligned inspection of overseas manufacturing facilities
Import Licence & Documentation
TGA manufacturing licence or sponsor licence for import; GMP clearance for each manufacturing site
Labeling & Packaging
Australian-specific labeling per TGO 91/92; English language; AUST R number
Note: TGA participates in PIC/S mutual recognition — PIC/S GMP certificate from India may expedite clearance.
Regulatory information is provided for general reference based on publicly available TGA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with TGA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Simvastatin from India and How Much Does APOTEX AUSTRALIA Import?
India exported $25.4M worth of Simvastatin through 3,854 shipments from 150 suppliers to 84 countries, serving 421 buyers globally. APOTEX AUSTRALIA imports $712.9K of this total, accounting for 0.5% of India's Simvastatin exports with 68 shipments from AUSTRALIA. This is verified from 68 customs shipment records covering 51 distinct formulations.
What Is the Average Order Value for APOTEX AUSTRALIA's Simvastatin Imports?
APOTEX AUSTRALIA's average Simvastatin order value is $10.5K per consignment, based on 68 shipments totaling $712.9K. APOTEX AUSTRALIA is based in AUSTRALIA and ranks #15 among all Simvastatin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Simvastatin to APOTEX AUSTRALIA?
APOTEX AUSTRALIA sources Simvastatin from 1 verified Indian supplier: CIPLA LIMITED ($712.9K, 100.0%). This is based on 68 customs records.
How Does APOTEX AUSTRALIA Compare to Other Simvastatin Importers?
APOTEX AUSTRALIA ranks #15 among 421 Simvastatin importers from India with a 0.5% market share. The top 3 importers are YUSEN LOGISTICS BENELUX BELGIUM ($8.9M), APL SWIFT SERVICES (MALTA) LTD., ($5.6M), MYLAN HUNGARY KFT, ($1.9M). APOTEX AUSTRALIA processed 68 shipments from AUSTRALIA.
About APOTEX AUSTRALIA
APOTEX AUSTRALIA imports 3 products worth $1.5M. Beyond Simvastatin, top products include Letrozole, Docusate. View the complete APOTEX AUSTRALIA profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Simvastatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Simvastatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: APOTEX AUSTRALIA matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as APOTEX AUSTRALIA's capped import value divided by total capped export value for Simvastatin across all Indian exporters.
- 5.Verified Records: This page is backed by 68 individual customs records matching APOTEX AUSTRALIA importing Simvastatin, covering 51 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 84+ countries, 421+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Simvastatin Import Data for APOTEX AUSTRALIA
Access order-level details, pricing data, supplier connections, and competitive analysis for APOTEX AUSTRALIA's Simvastatin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
APOTEX AUSTRALIA
Full Company Profile →
3 products · $1.5M total trade · 3 categories
APOTEX AUSTRALIA × Simvastatin
Verified from customs records
Company Overview
Top Products by APOTEX AUSTRALIA
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for APOTEX AUSTRALIA.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Simvastatin. For current order-level data, contact TransData Nexus.